UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Recruitment status Completed
Unique ID issued by UMIN UMIN000014645
Receipt No. R000016988
Scientific Title Safety and effectiveness of body contouring surgery after bariatric surgery
Date of disclosure of the study information 2014/07/28
Last modified on 2018/08/10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Safety and effectiveness of body contouring surgery after bariatric surgery
Acronym Body contouring surgery after bariatric surgery
Scientific Title Safety and effectiveness of body contouring surgery after bariatric surgery
Scientific Title:Acronym Body contouring surgery after bariatric surgery
Region
Japan

Condition
Condition Patients suffering from the discomfort caused by the excessive loose skin following bariatric surgery
Classification by specialty
Plastic surgery
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate patient satisfaction and complication rate of body contouring surgeries when performed on patients with weight loss due to bariatric surgeries
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2
Developmental phase Not applicable

Assessment
Primary outcomes Assessment of body contouring by photograph at post op. 6 month, 12month
Key secondary outcomes 1. Post operative conplications 2. Patient satisfaction at post op. 6 month, 12month

In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field.

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 surgical resection of skin fold caused by bariatric surgery
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required.

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1. Patients suffering from skin folds after bariatric surgery.
2. Patients are followed over one year after bariatric surgery.
3. Consecutive 3 monthly body weight changes are within 5 % of excessive body weight. The calculation of excessive body weight are pre-bariatric surgery weight minus ideal body weight.
Key exclusion criteria 1, severe cardiac failure, major pulmonary dysfunction
2, patients who cannot be followed or denied to be followed up
3, pregnant patients
4, patients with coagulopathy
5, patients who are attending other experimental protocol

Target sample size 9

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Masahiro Tachi
Organization Graduate School of
Medicine, Tohoku University
Division name Department of Plastic and Reconstructive Surgery
Zip code
Address 2-1, Seiryo-machi, Aoba-ku, Sendai,
TEL 0227177748
Email tachi@med.tohoku.ac.jp

Public contact
Name of contact person
1st name
Middle name
Last name Yoshimichi Imai
Organization Graduate School of
Division name Department of Plastic and Reconstructive Surgery
Zip code
Address 2-1, Seiryo-machi, Aoba-ku, Sendai,
TEL 0227177748
Homepage URL
Email yo-imai@med.tohoku.ac.jp

Sponsor
Institute Graduate School of
Medicine, Tohoku University
Institute
Department

Sponsor means an organization that is responsible for plan, deployment and
report of the research including funding management. It doesn't mean
funding agency". Therefore, all clinical trial should have the one.

Funding Source
Organization Management Expenses Grants
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 東北大学病院(宮城県)

Other administrative information
Date of disclosure of the study information
2014 Year 07 Month 28 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Completed
Date of protocol fixation
2014 Year 06 Month 24 Day
Date of IRB
Anticipated trial start date
2014 Year 08 Month 25 Day
Last follow-up date
2018 Year 05 Month 31 Day
Date of closure to data entry
2018 Year 05 Month 31 Day
Date trial data considered complete
2018 Year 07 Month 21 Day
Date analysis concluded
2018 Year 12 Month 25 Day

Other
Other related information

Management information
Registered date
2014 Year 07 Month 25 Day
Last modified on
2018 Year 08 Month 10 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016988


Contact us.